Therapeutic Psychedelics – Opportunities and Impact

Moderators

Maurizio Fava, MD

Chair, Department of Psychiatry, Massachusetts General Hospital;

Slater Family Professor of Psychiatry, Harvard Medical School

Jason Gerberry

Specialty Pharma and SMid-Cap Biotech Analyst, BofA Global Research

Kerry Ressler, MD, PhD

Chief Scientific Officer, McLean Hospital;

Professor of Psychiatry, Harvard Medical School

Panelists

Cristina Cusin, MD

Director, MGH Ketamine Clinic and Psychiatrist, Depression Clinical and Research Program, Massachusetts General Hospital;

Associate Professor in Psychiatry, Harvard Medical School

Daniel Karlin, MD

Chief Medical Officer, MindMed

John Krystal, MD

Chair, Department of Psychiatry, Yale School of Medicine

Jennifer Warner-Schmidt, PhD

Vice President, Scientific Affairs, Transcend Therapeutics